Production (Stage)
Scinai Immunotherapeutics Ltd.
SCNI
$2.69
-$0.0407-1.49%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.96M | 3.08M | 4.87M | 6.36M | 10.80M |
| Total Receivables | 217.00K | 119.00K | 366.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 79.00K | 324.00K | 71.00K | 228.00K | 119.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 131.00K | 138.00K | 140.00K | 122.00K | 127.00K |
| Total Current Assets | 2.39M | 3.66M | 5.45M | 6.71M | 11.05M |
|
|
|||||
| Total Current Assets | 2.39M | 3.66M | 5.45M | 6.71M | 11.05M |
| Net Property, Plant & Equipment | 11.06M | 11.19M | 12.03M | 11.87M | 12.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.45M | 14.85M | 17.47M | 18.58M | 23.29M |
|
|
|||||
| Total Accounts Payable | 376.00K | 658.00K | 535.00K | 546.00K | 1.31M |
| Total Accrued Expenses | 781.00K | -- | 849.00K | 610.00K | 846.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 424.00K | 364.00K | 396.00K | 382.00K | 420.00K |
| Total Finance Division Other Current Liabilities | 225.00K | 650.00K | -- | -- | -- |
| Total Other Current Liabilities | 225.00K | 650.00K | -- | -- | -- |
| Total Current Liabilities | 1.81M | 1.67M | 1.78M | 1.54M | 2.58M |
|
|
|||||
| Total Current Liabilities | 1.81M | 1.67M | 1.78M | 1.54M | 2.58M |
| Long-Term Debt | 260.00K | 19.82M | 19.37M | 18.60M | 21.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.40M | 640.00K | 797.00K | 823.00K | 1.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.00K | 3.00K | 96.00K | 311.00K | 2.66M |
| Total Liabilities | 3.47M | 22.14M | 22.04M | 21.27M | 28.10M |
|
|
|||||
| Common Stock & APIC | 123.63M | 121.27M | 119.51M | 119.05M | 116.43M |
| Retained Earnings | -117.54M | -126.82M | -122.34M | -120.01M | -119.35M |
| Treasury Stock & Other | -1.74M | -1.74M | -1.74M | -1.74M | -1.89M |
| Total Common Equity | 4.35M | -7.28M | -4.57M | -2.69M | -4.81M |
|
|
|||||
| Preferred Stock Redeemable | 5.63M | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.63M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.35M | -7.28M | -4.57M | -2.69M | -4.81M |
| Total Preferred Equity | 5.63M | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.98M | -7.28M | -4.57M | -2.69M | -4.81M |
|
|
|||||